HHV6 was first described in 1986, and since then studies have attempted to discover the sites of active or latent infection. Salivary glands have been implicated because of the high isolation rate of HHV6 from saliva.' Two studies found virus at this site using both immunocytochemical and nucleic acid hybridisation techniques, and an avidin-biotin detection system.23
The increasing use of biotin labelled detec- HHV6, independent of the detection system; non-infected cells incubated with HHV6 antisera and infected cells stained with NMS were uniformly negative.
Focal, cytoplasmic positivity was also seen when only the avidin-peroxidase (sABC or sAPo) reagents were applied. No staining of any kind was seen using the two-stage ShaMPo system.
Biotin was detected in all the 20 salivary glands stained. Staining was intense in the cytoplasm of the duct lining cells, scattered serous acini and mucous acinar epithelial cells (figs 2 and 3) . In the six further non-salivary gland tissues biotin was detected in the gland/ duct/follicle lining cells and in interstitial macrophages and plasma cells.
The use of trypsin eliminated the spurious nuclear staining but had no effect on the salivary duct positivity. Pepsin seemed to increase the level of avidin binding. However, pepsin greatly reduced the positivity of the HHV6 stained J-Jhan cells. Neither above digestion protocol, nor that suggested by Fox et a12 (0-4% pepsin for 20-30 minutes), produced any unequivocal staining for HHV6.
The 15 assorted frozen submandibular, parotid, and minor salivary glands were uniformly negative for HHV6, although the control cells were well stained by the technique used.
Discussion
Fox et al found HHV6 by in situ hybridisation and immunocytochemistry in the nuclei of serous cells and in both the nuclei and cytoplasm of mucous and duct columnar cells in a high proportion of the salivary glands studied. 2 We were not able to reproduce these results in either paraffin wax or frozen sections. However, we have shown avidin-binding material and non-specific nuclear staining in most of the above sites. Contrary to the findings of Fox et al was the almost total loss of HHV6 staining after pepsin digestion of sections of infected J-Jhan cells. This would indicate that pepsin destroys the HHV6 antigen in infected cell culture material and presumably in tissue sections also. Methanol-peroxide and phenylhydrazine inhibition of endogenous peroxidase had no effect on the demonstration* of HHV6.
These discrepancies may be due to the use of different antibodies, tissue fixation regimens, or staining protocol. Other work in our laboratory on mouse kidney (F H Carpenter, personal communication) suggests that tissue fixation has an important role in subsequent reactivity with anti-biotin. Primary fixation in formol-sublimate resulted in no demonstrable endogenous biotin; with Carnoy's and Bouin's fixatives tissue contained large amounts. With formalin the endogenous biotin was intermediate but reduced further as the time of fixation increased. Thus studies describing results derived from the use of avidin-biotin complex (ABC) detection systems should state the type and duration of tissue fixation.
In 1981 Hsu et al claimed that "no unwanted staining is derived from intrinsic biotin" in their test tissues, including thyroid, liver and breast.5 Most workers now agree that of those tissues, liver contains sufficient endogenous biotin to cause problems with ABC techniques, and we have further shown the presence of intrinsic avidin binding material not only in thyroid and breast but also a range of glandular tissues.
Although the intensity of non-specific staining produced by the avidin-biotin technique was less than that seen in the positive controls or the biotin stained sections, it was still above background levels and could be mistaken for positivity. This must place constraints on the interpretation of results obtained using biotinylated antibodies or cDNA probes, and emphasises the need for strict controls.
The use of the anti-biotin antibody showed the extent of endogenous biotin in the tissues tested, and this antibody would provide an ideal staining control for avidin-biotin detection systems, especially when results are weak or equivocal.
